Why Your Fragrance SDS Just Says Parfum and What to Do
Your supplier's safety data sheet listing only parfum is normal, not a stonewall, and there is a specific way to get the real data.
Your supplier's safety data sheet listing only parfum is normal, not a stonewall, and there is a specific way to get the real data.
Why kills-germs wording on a soap label moves it out of cosmetic notification and into drug labeling territory.
How the Cosmetic Ingredient Hotlist treats boric acid and sodium borate, and why powders and children's products get separate rules.
A quick way to check whether your formula is hit by the April 12 List 1 deadline, the August 1 List 2 deadline, or both.
How to state a hero ingredient's percentage on a cosmetic label truthfully and keep it matched to the actual formula.
How stretch mark cream wording decides whether you are filing a cosmetic notification or stepping into drug territory.
A close, line-by-line read of SDS Section 3 showing exactly where to find each ingredient's CAS number and concentration range.
The exact triggers, claims, ingredients, and form, that turn an exempt bar of true soap into a cosmetic requiring a CNF filing.
How to build a simple change log for formula edits so you can prove which batch used which recipe version if anyone asks.
How a barrier and rash-treatment diaper cream ends up classified as a drug while a plain baby lotion stays a cosmetic.
Anticavity and antigingivitis claims put fluoride toothpaste in drug territory, and why that matters if you are branching into oral care.
A troubleshooting list of the frequent mistakes that cause rejected or inaccurate MoCRA product listings, and how to fix each one.
The common formaldehyde-releasing preservatives on Canada's Hotlist, their restriction conditions, and why free formaldehyde needs a warning.
Whether saponified soap should declare sodium hydroxide, the fatty acids, or the resulting sodium salts, explained for filing purposes.
Mica's INCI and CI number explained, and why coated pearlescent pigments must list mica plus a separate colorant like titanium dioxide.
How branded peptide complexes and trademarked extract blends resolve to the plain INCI names you actually have to file.
Escalation steps and workarounds when a fragrance house stalls on allergen breakdowns before your Canada CNF deadline.
How to legally sell down existing inventory while new compliant labels roll into production, without a recall or a wasted pallet.
How to spot Hotlist entries with tighter limits or added conditions specifically for products intended for children and infants.
What triclosan's restricted status on Canada's Hotlist actually permits, and why an antibacterial claim can push your product into drug territory.
The legal logic behind AICIS classifying cosmetic ingredients as industrial chemicals rather than regulating finished cosmetic products directly.
How the US, EU, and Australia treat SPF products differently, and where sunscreen claims can knock your notification out of the cosmetic lane.
Whether giveaway samples, deluxe minis, and retail testers count as a sale that triggers Canada's Cosmetic Notification requirement.
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.